TITLE

Antiplatelet Therapy for Atherothrombotic Disease: An Update for the Primary Care Physician

AUTHOR(S)
Kikano, George E.; Brown, Marie T.
PUB. DATE
May 2007
SOURCE
Mayo Clinic Proceedings;May2007, Vol. 82 Issue 5, p583
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Atherothrombosis is a progressive and generalized pathologic process that affects the vascular system. Clinical manifestations of atherothrombosis depend on the affected vascular bed and include acute coronary syndromes, stroke, and peripheral arterial disease. Ischemia associated with atherothrombosis is highly prevalent, affecting millions of people each year. Many patients experience multiple ischemic events within the first year of an initial event. The mainstay for prevention includes risk factor management through lifestyle modification and treatment of underlying disease. Guidelines have been published for secondary prevention of atherothrombosis-related cardiovascular disease, including use of various long-term pharmacotherapies, such as antiplatelet agents, statins, and angiotensin-converting enzyme inhibitors. Implementation of effective treatment strategies requires an awareness of the guidelines by physicians to ensure that both acute therapy and long-term management are addressed. This review is based on treatment guidelines and selected peer-reviewed publications identified through a MEDLINE and PubMed literature search, primarily from January 1996 to December 2006, that relate to clinical trials of antiplatelet therapy in patients with atherothrombotic disease. Secondary prevention strategies for patients with atherothrombosis are discussed, highlighting current guideline recommendations and programs designed to encourage a continuum of care from the acute to the ambulatory setting.
ACCESSION #
25242037

 

Related Articles

  • Exercise for the Mind. Field, Stanford // Townsend Letter;Jun2008, Issue 299, p93 

    The article discusses various theories of heart disease. The ghomocysteiene theory is based on the reality that a dietary imbalance between too much methionine and a lack of methylating nutrients is an underlying reason of death and disability from vascular diseases. The basis of the collagen...

  • Physician Attitudes Regarding Cardiovascular Risk Reduction: The Gaps Between Clinical Importance,Knowledge, and Effectiveness. Castaldo, John; Nester, Jane; Wasser, Tom; Masiado, Tamara; Rossi, Michael; Young, Mark; Napolitano, Joseph J.; Schwartz, J. Sanford // Disease Management;Apr2005, Vol. 8 Issue 2, p93 

    Reducing risk factors for patients with vascular disease can reduce the subsequent incidence of cerebro-cardiovascular disease. While physicians have had extensive training in the importance of atherosclerotic vascular disease risk factor modification, evidence suggests that they systematically...

  • Circulating Angiogenic Factors in Patients with Thromboangiitis Obliterans. Hewing, Bernd; Stangl, Verena; Stangl, Karl; Enke-Melzer, Kathrin; Baumann, Gert; Ludwig, Antje // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Background: Thromboangiitis obliterans (TAO, also known as Buerger's disease) is a non-atherosclerotic inflammatory vascular disease that primarily affects arteries in the extremities of young adult smokers. Since the etiology of TAO is still unknown, therapeutic options are limited. Recent...

  • Antiplatelet use for CVD prevention.  // GP: General Practitioner;3/17/2006, p16 

    The article presents the results of the Clopidogrel for High Atherothrombotic Risk and Ischaemic Stabilisation, Management and Avoidance trial of 15,603 patients with multiple cardiovascular risk factors. The results show that dual antiplatelet therapy is beneficial for secondary prevention in...

  • The conundrum of ALI and systemic embolic events: SEEing our way to improved vascular health. Hirsch, Alan T.; Van’t Hof, Jeremy R.; Bonaca, Marc // Vascular Medicine;Dec2016, Vol. 21 Issue 6, p535 

    The article discusses vascular emergency in patients with acute limb ischemia (ALI) and atherothrombosis. Topics discussed include irresponsive clinical investigation for ALI incidence, absence of emergency platform for treating sudden disruption of arterial blood flow and offers suggestions for...

  • Multimodality vascular imaging in CKD: divergence of risk between measured parameters. Petchey, William G.; Hawley, Carmel M.; Johnson, David W.; Haluska, Brian A.; Watkins, Trevor W.; Isbel, Nicole M. // Nephrology Dialysis Transplantation;Mar2012, Vol. 27 Issue 3, p1004 

    Background. High cardiovascular risk in chronic kidney disease (CKD) patients appears only partly attributable to atherosclerosis, with much of the remaining risk being ascribed to other vasculature abnormalities, including endothelial dysfunction, arterial stiffness and vascular calcification...

  • The analysis of the connection between plaque morphology of asymptomatic carotid stenosis and ischemic brain lesions. Milosevic, Djordje; Pasternak, Janko; Popović, Vladan; Nikolić, Dragan; Milosevic, Pavle; Manojlović, Vladimir // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Nov2013, Vol. 70 Issue 11, p993 

    Background/Aim. A certain percentage of patients with asymptomatic carotid stenosis have an unstable carotid plaque. For these patients it is possible to register the existence of lesions of the brain parenchyma -- the silent brain infarction. These patients have a greater risk of ischemic...

  • When walking hurts.  // Consumer Reports on Health;Jul99, Vol. 11 Issue 7, p10 

    Provides information on peripheral vascular disease generally caused by plaque buildup in an artery. Pain triggered by walking as a symptom that the working muscles are not getting enough oxygen; Diagnosis and treatment by a medical practitioner.

  • Peripheral Arterial Disease. Anand, Sonia S.; Creager, Mark A. // American Family Physician;6/1/2002, Vol. 65 Issue 11, p2321 

    Presents information on the peripheral arterial disease. Symptoms of atheroma; Factors associated with the development of peripheral arterial disease; Comparison between the effectiveness of antiplatelet agents and control treatments in reducing the rate of cardiovascular events and local...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics